Edith Heard Unanimously Selected as Next Director General of EMBL

News   Jul 13, 2017 | Original Story from the EMBL

 
Edith Heard Unanimously Selected as Next Director General of EMBL

Edith Heard has been selected as EMBL's next Director General.

 
 
 

RELATED ARTICLES

Medivir Outsources Compound Management to BioAscent

News

BioAscent is now managing 56,000 samples of Medivir's compound collection for their ongoing drug discovery activities.

READ MORE

Mouse Model of Human Immune System Inadequate for Stem Cell Studies

News

“Humanized” mice are used to study human immune responses, but they are inadequate for stem cell studies, say Stanford researchers. Optimized models are needed for clinical decision-making.

READ MORE

New Technique Overcomes Genetic Cause of Infertility

News

Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE